Protagenic Therapeutics, Inc.\new Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Protagenic Therapeutics, Inc.\new Depreciation for the quarter ending September 30, 2024 was $12.6K, a 786% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new Depreciation for the twelve months ending September 30, 2024 was $64.3K.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2023 was $28.2K, a 93960% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2022 was $30.000.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2020 was $286.000, a 15.6% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28.2K +$28.2K +93960% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 $30.00 Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2020 $286 -$53 -15.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-07
2019 $339 -$8 -2.31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $347 +$199 +134% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-29
2017 $148 -$386 -72.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $534 +$391 +273% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $143 -$237 -62.4% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-05-08
2014 $380 Jan 1, 2014 Dec 31, 2014 8-K/A 2016-07-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.